Target intelligence / Profile preview

Voltage-gated sodium channel alpha-subunit extracellular site 3 (NaV site 3)

Target
NaV site 3
Molecular classification
Ion channel, Voltage-gated sodium channel
01

Overview

The term "Other NaV channel alpha-subunits, extracellular site 3" refers to the neurotoxin receptor site 3 found across the various isoforms of the voltage-gated sodium channel (NaV) family, including NaV1.1 through NaV1.9 (Alexander et al., 2021). These alpha-subunits are large transmembrane proteins that form the ion-conducting pore and are essential for the generation and propagation of action potentials in neurons, cardiomyocytes, and skeletal muscle cells (Catterall, 2012). Extracellular site 3 is specifically located on the S3-S4 loop of domain IV and serves as the binding target for alpha-scorpion toxins and sea anemone toxins (Stevens et al., 2011). Binding at this site impairs the voltage-sensing mechanism of domain IV, which is coupled to the fast inactivation process, thereby slowing channel closure and causing persistent sodium influx (Gordon et al., 1996). This prolonged activation leads to cellular hyperexcitability, which is a hallmark of various channelopathies, including epilepsy, chronic pain syndromes, and cardiac arrhythmias (Catterall, 2012). While site 3 is primarily used as a pharmacological tool to study channel gating, it represents a potential target for developing modulators that can fine-tune excitability in specific tissues (Stevens et al., 2011).

Other names
Neurotoxin receptor site 3Alpha-scorpion toxin binding siteSea anemone toxin binding siteNaV extracellular site 3Voltage-gated sodium channel site 3
02

Mechanism of action

Binding to the extracellular S3-S4 loop of domain IV slows the inactivation of the sodium channel, prolonging the inward sodium current and increasing membrane excitability.

03

Biological functions

Action potential propagationSodium ion transportRegulation of channel inactivation
04

Disease associations

EpilepsyPainCardiac arrhythmiaNeuromuscular disorder
05

Safety considerations

NeurotoxicityPro-arrhythmic potentialSeizure inductionHyperexcitabilityMuscle paralysis
06

Interacting drugs

Alpha-scorpion toxin

5 more in the full profile.

07

Biomarkers

Sodium current inactivation kineticsPatch-clamp electrophysiologyAction potential duration

Beyond the preview

Go deeper on Voltage-gated sodium channel alpha-subunit extracellular site 3 (NaV site 3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated sodium channel alpha-subunit extracellular site 3 (NaV site 3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call